Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

NCT00347841 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Bimatoprost 0.03%, Latanoprost

Sponsor

Innovative Medical